La cadena de opciones muestra datos clave de las opciones de acciones de CervoMed a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para CervoMed..

CervoMed (NASDAQ:CRVO) Bolsa, Cadena de Opciones

CERVOMED INC

CervoMed

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

CervoMed Inc

Press Releases

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

News

CervoMed Announces Late-Breaking Presentations at Alzheimer's Association® International Congress 2025

CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference Call on July 28, 2025

Health Care

CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod's Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated Reduction in a Key Plasma Biomarker of Neurodegeneration

Peraso (NASDAQ: PRSO) Powers Military, Nex-Gen Broadband Surge – Mag 7 Undercard VAPE CELC, CRVO – More Stocks Inside

CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference

Earnings

CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

CervoMed to Participate in Upcoming Investor Conferences

CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference

CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

CELC

CRVO

LOOP

PNPNF

PRSO

SNYR

TSXV:PNPN

VAPE

ABVC BioPharma

Adicet Bio

Aligos Therapeutics

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

aTyr Pharma

BeyondSpring

Cibus

Clene

CEL-SCI

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Fortress Biotech

Gain Therapeutics

Immix Biopharma

MiNK Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

MediciNova

OKYO Pharma

OS Therapies

PMV Pharma

Plus Therapeutics

Repare Therapeutics

Sutro Biopharma

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

HC Wainwright & Co.

D. Boral Capital

Roth Capital

Chardan Capital

Canaccord Genuity

Screenshot 2024-11-26 at 7.00.24 PM

Biotech

Interview

General

Clinical Trial Results Show Positive Signs For Potential New Dementia Treatment

Comments

CervoMed

CervoMed (CRVO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL